Clover Health Investments Corp. - Class A (CLOV) closed at $4.96 on November 13, 2026, up 1.6% from the previous close, on volume of 3,858,705 shares (30-day average 4,489,172).
Data as of November 13, 2026.
13-Nov-2026
| # | Date | Strategy | Legs | Contracts | Position |
|---|---|---|---|---|---|
| 1 | Nov 4, 2026 | Put Spread | 13-Nov-264 : 4.5 P | 11,220 | |
| 2-3 | The next 2 largest trades are for Premium members. Start a 7-day free trial | ||||
Ranked by contracts: multi-leg trades of 200 or more contracts on one day, through Nov 13, 2026. See the 10 largest for 30, 60 and 90 days
BrightSpring, Centene stand out as healthcare's most persistent Strong Buys
Seeking Alpha News (Thu, 12-Nov 7:38 AM ET)
Clover Health Reports Third Quarter 2026 Results
Globe Newswire (Wed, 4-Nov 4:05 PM ET)
Clover Health to Participate in Upcoming UBS Global Healthcare Conference
Globe Newswire (Mon, 26-Oct 4:05 PM ET)
Globe Newswire (Mon, 19-Oct 4:30 PM ET)
Market Chameleon (Fri, 9-Oct 7:48 AM ET)
Clover Health’s wide-network PPO earns a 5-Star CMS rating for 2027, unlocking year-round enrollment
Market Chameleon (Fri, 9-Oct 3:06 AM ET)
Clover Health Medicare Advantage PPO Plans Earn 5 Star Rating for 2027
Globe Newswire (Thu, 8-Oct 6:45 PM ET)
Clover Health to Report Third Quarter 2026 Financial Results on November 4, 2026
Globe Newswire (Wed, 7-Oct 4:05 PM ET)
Clover Health's 2027 Medicare Advantage Plans Emphasize PPO Choice, Preventive Care and Member Value
Globe Newswire (Thu, 1-Oct 8:00 AM ET)
Globe Newswire (Thu, 24-Sep 5:55 PM ET)
Clover Health Investments Corp is a healthcare technology company. It focuses on empowering Medicare physicians to proactively manage chronic diseases through its proprietary software platform, Clover Assistant. This cloud-based solution provides personalized insights to physicians, enabling early detection and management of chronic conditions. It operates in one segment: Insurance, through which it offers PPO and HMO plans to Medicare Advantage members in several states.
Clover Health Investments Corp. - Class A trades on the NASDAQ stock market under the symbol CLOV.
As of November 13, 2026, CLOV stock price climbed to $4.96 with 3,858,705 million shares trading.
CLOV has a beta of 2.18, meaning it tends to be more sensitive to market movements. CLOV has a correlation of 0.16 to the broad based SPY ETF.
CLOV has a market cap of $2.63 billion. This is considered a Mid Cap stock.
Last quarter Clover Health Investments Corp. - Class A reported $759 million in Revenue and $.01 earnings per share. This beat revenue expectation by $19 million and met earnings estimates .
In the last 3 years, CLOV traded as high as $5.59 and as low as $.61.
The top ETF exchange traded funds that CLOV belongs to (by Net Assets): VTI, IWM, VXF, IWO, SCHA.
CLOV has outperformed the market in the last year with a price return of +100.8% while the SPY ETF gained +13.4%. CLOV has also outperformed the stock market ETF in the last 3 month and 2 week periods returning +10.5% and +11.2%, respectively, while the SPY returned -2.8% and -0.2%, respectively.
CLOV support price is $4.66 and resistance is $5.10 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that CLOV shares will trade within this expected range on the day.
